A leading medical expert has claimed the privatisation of drug company CSL contributed to the rationing of benzyl penicillin, an important antibiotic for public health.
CSL
Investigation launched into possible flu vaccine contamination
The Therapeutic Goods Administration will publish its own investigation into CSL flu shot manufacturing irregularities in the wake of an inspection by US authorities on CSL Biotherapies in April.
Tips and rumours: Trading Post’s Telstra-esque customer service
Billing issues across Telstra’s departments? Never. But don’t worry, the new CEO will take care of all that. Plus, which indigenous activist and intellectual is anxiously scanning YouTube for old modelling footage of herself?
China, the dollar and feds’ stimulus the shape of things to come
The shaping factors for the Australian economy and business over the next year were seen yesterday: China, the strength of the Aussie dollar and the federal government’s stimulus spending produced good and bad news for some leading companies and the economy generally.
Morning Market Report: CSL announces $1.59bn share buyback
CSL Ltd has announced it will undertake a $1.59bn share buyback after the $3.1bn takeover of Talecris fell through.
Morning Market Report: Market down 45, Dow down 173
The market is down 45, but ANZ is holding up well after its $2.5bn institutional placement at 1440c.
Morning Market Report: CSL loses Talecris
US Equities and Treasuries Markets closed For The Memorial Day Public Holiday. UK markets closed for the Spring Bank Holiday. Here’s what action there is on markets.
Morning Market Report: ASIC remove the shortening ban on financials
ASIC have ended the shortening ban early, while the market and the Dow are down.
